Skip to main content
. Author manuscript; available in PMC: 2015 Sep 1.
Published in final edited form as: Adv Healthc Mater. 2014 Mar 24;3(9):1448–1456. doi: 10.1002/adhm.201300688

Figure 3.

Figure 3

A) In vitro release profile of GW3965 from PLA-PEG/PLGA/GW NPs incubated at 37 °C is shown (mean ±SD, n = 3). The LXR agonist released from the NPs at different time points was quantified by HPLC. B) Transition electron microscopy (TEM) images of LXR agonist containing NPs formed by blending PLA-PEG-COOH and PLGA-GW polymers (Scale bar, 100 nm).